Pavoni et al. utilized small molecule inducers, such as the Aβ inducer Aftin-5, to elicit AD-like pathologies in organoids, exhibiting a significant increase in Aβ accumulation and neuronal loss, but failed to induce substantial changes in p-tau levels [38]. This evidence concerns the gene MAPT and Alzheimer disease.